<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05107167</url>
  </required_header>
  <id_info>
    <org_study_id>STIMIT-IA</org_study_id>
    <nct_id>NCT05107167</nct_id>
  </id_info>
  <brief_title>Electromagnetic Stimulation of the Phrenic Nerve of Intubated Patients With Obesity</brief_title>
  <acronym>STIMIT-IA</acronym>
  <official_title>Electromagnetic Stimulation of the Phrenic Nerve to Generate Contraction of the Diaphragm in Anesthetized and Intubated Patients With Obesity - a Proof-of-concept Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stimit AG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ventilator-induced diaphragmatic dysfunction is a common issue in critically ill patients.&#xD;
      Muscle stimulation has shown to have beneficial effects in muscle groups on the extremities.&#xD;
      A non-invasive way to stimulate the diaphragm would be the electromagnetic stimulation but it&#xD;
      is currently unclear if that is feasible.&#xD;
&#xD;
      In this proof-of-concept trial the primary aim is to show that it is possible to induce a&#xD;
      diaphragmatic contraction leading to an inspiration with a sufficient tidal volume via an&#xD;
      external electromagnetic stimulation of the phrenic nerve in obese patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During the time of first spontaneous breathing trial 60% of mechanically ventilated patients&#xD;
      present with diaphragmatic weakness or also know as ventilator-induced diaphragmatic&#xD;
      dysfunction (VIDD). The damage to the diaphragm in terms of muscle atrophy has been shown as&#xD;
      early as 12 hours after initiation of mechanical ventilation. Recently, a correlation between&#xD;
      diaphragmatic atrophy and mortality could be established.&#xD;
&#xD;
      Induction of diaphragmatic contractions via stimulation of the phrenic nerve would be a&#xD;
      possible method to prevent or treat VIDD. A possible modality would be the non-invasive&#xD;
      electromagnetic stimulation but feasibility has not been established.&#xD;
&#xD;
      In this proof-of-concept trial the primary aim is to show that it is possible to induce a&#xD;
      diaphragmatic contraction leading to an inspiration with a sufficient tidal volume via an&#xD;
      external electromagnetic stimulation of the phrenic nerve in obese patients&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>1.Tidal volume generated by electromagentical stimulation of the phrenic nerve (ml)</measure>
    <time_frame>approximately 15 minutes</time_frame>
    <description>Mean tidal volume of 10 consecutively stimulations of the phrenic nerve</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Max inspiratory flow after stimulation</measure>
    <time_frame>approximately 15 minutes</time_frame>
    <description>The maximal air flow created in the duct following stimulation of the N. phrenicus (meter / second)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abdominal extension maximum</measure>
    <time_frame>approximately 15 minutes</time_frame>
    <description>Extension of the abdomen measured via in abdominal belt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Air pressure during each breath</measure>
    <time_frame>approximately 15 minutes</time_frame>
    <description>Change in pressure in the duct from expiration to inspiration (mbar)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diaphragmatic thickening fraction</measure>
    <time_frame>approximately 15 minutes</time_frame>
    <description>Diaphragmatic contractility measured by ultrasound after N. phrenicus stimulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feedback/Stimulation locus relation</measure>
    <time_frame>approximately 15 minutes</time_frame>
    <description>When the stimulation locus is changed according to protocol the change of the triggered tidal volume is measured in % to the original location</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Latency between stimulation and feedback</measure>
    <time_frame>approximately 15 minutes</time_frame>
    <description>Time between start and end of the stimulation in seconds</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensity/Contractility relation</measure>
    <time_frame>approximately 15 minutes</time_frame>
    <description>Correlation between the simulation intensity and the diaphragmatic contractility</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to find the optimal stimulation point of the N. phrenicus</measure>
    <time_frame>approximately 15 minutes</time_frame>
    <description>Time between first successful N. phrenicus stimulation and identification of the optimal stimulation locus in seconds</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distance between anatomical landmarks and optimal stimulation locus</measure>
    <time_frame>approximately 15 minutes</time_frame>
    <description>Distance between anatomical landmarks and optimal stimulation locus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reproducibility of stimulation answer</measure>
    <time_frame>approximately 15 minutes</time_frame>
    <description>Variation of stimulated tidal volumes and diaphragm contraction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Adverse Events during stimulation</measure>
    <time_frame>approximately 15 minutes</time_frame>
    <description>Adverse Events elicited by the electromagnetic stimulation</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">5</enrollment>
  <condition>General Anaesthesia</condition>
  <condition>Muscle Weakness</condition>
  <arm_group>
    <arm_group_label>Electromagnetic stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Electromagnetic stimulation of the phrenic nerve.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electromagnetic stimulation</intervention_name>
    <description>Electromagnetic stimulation of the phrenic nerve</description>
    <arm_group_label>Electromagnetic stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ≥ 18 years of age&#xD;
&#xD;
          -  American Society of Anaesthesiologists Classification I or II&#xD;
&#xD;
          -  Planned anesthesia with intubation&#xD;
&#xD;
          -  Adipositas Grade II-III&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chronic lung disease&#xD;
&#xD;
          -  Preexisting diaphragmatic weakness&#xD;
&#xD;
          -  Neurologic disease with known motor weakness&#xD;
&#xD;
          -  Paralysis of the phrenic nerve&#xD;
&#xD;
          -  Contraindication for any movement in the cervical vertebrae&#xD;
&#xD;
          -  Conditions that limit the movement of the diaphragm e.g. ascites, increased&#xD;
             intraabdominal pressure.&#xD;
&#xD;
          -  Inability to communicate in the official language&#xD;
&#xD;
          -  Infections, lesions or stricture in the neck area&#xD;
&#xD;
          -  Implanted cardiac devices e.g. pace maker, defibrillator, event recorder&#xD;
&#xD;
          -  Implanted medical pumps e.g. left ventricular assist device&#xD;
&#xD;
          -  Metal implants in the upper body&#xD;
&#xD;
          -  Preganancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan J Schaller, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charité - Universitätsmedizin Berlin, Berlin, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefan J Schaller, Prof. Dr.</last_name>
    <phone>+49 30 450 531 052</phone>
    <email>stefan.schaller@charite.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Charité - Univiversitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 26, 2021</study_first_submitted>
  <study_first_submitted_qc>October 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2021</study_first_posted>
  <last_update_submitted>October 26, 2021</last_update_submitted>
  <last_update_submitted_qc>October 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Stefan J Schaller</investigator_full_name>
    <investigator_title>Deputy Clinical Director</investigator_title>
  </responsible_party>
  <keyword>VIDD</keyword>
  <keyword>ICUAW</keyword>
  <keyword>muscle weakness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Weakness</mesh_term>
    <mesh_term>Paresis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Deidentified data can be requested on reasonable scientific request.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>After publication of scientific manuscript.</ipd_time_frame>
    <ipd_access_criteria>Deidentified data can be requested on reasonable scientific request.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

